News for Healthier Living

Study Finds SGLT-2 Inhibitors Linked to Lower Risk of Diabetic Foot Nerve Damage

A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium-glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing diabetic foot problems compared to those taking glucagon-like peptide-1 (GLP-1) receptor agonists.

January 5, 2026


January 19 2026

January 18 2026

January 17 2026

January 16 2026

January 15 2026

January 14 2026

January 13 2026

January 12 2026

January 11 2026

January 10 2026

January 9 2026

January 8 2026

January 7 2026

January 6 2026